MaxCyte, Inc.
MXCT
$1.52
-$0.05-3.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.42M | 35.75M | 37.68M | 38.63M | 45.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.42M | 35.75M | 37.68M | 38.63M | 45.60M |
| Cost of Revenue | 6.89M | 7.23M | 7.19M | 7.10M | 6.39M |
| Gross Profit | 27.53M | 28.53M | 30.48M | 31.53M | 39.21M |
| SG&A Expenses | 51.73M | 55.72M | 56.11M | 56.36M | 57.96M |
| Depreciation & Amortization | 4.21M | 4.18M | 4.14M | 4.14M | 4.19M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.93M | 89.23M | 88.89M | 89.83M | 91.99M |
| Operating Income | -50.51M | -53.48M | -51.22M | -51.20M | -46.39M |
| Income Before Tax | -45.63M | -44.77M | -41.79M | -41.06M | -35.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.63 | -44.77 | -41.79 | -41.06 | -35.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.63M | -44.77M | -41.79M | -41.06M | -35.74M |
| EBIT | -50.51M | -53.48M | -51.22M | -51.20M | -46.39M |
| EBITDA | -46.21M | -49.17M | -46.92M | -46.88M | -42.03M |
| EPS Basic | -0.43 | -0.42 | -0.40 | -0.39 | -0.34 |
| Normalized Basic EPS | -0.25 | -0.26 | -0.25 | -0.24 | -0.21 |
| EPS Diluted | -0.43 | -0.42 | -0.40 | -0.39 | -0.34 |
| Normalized Diluted EPS | -0.25 | -0.26 | -0.25 | -0.24 | -0.21 |
| Average Basic Shares Outstanding | 424.51M | 423.01M | 421.25M | 419.39M | 417.54M |
| Average Diluted Shares Outstanding | 424.51M | 423.01M | 421.25M | 419.39M | 417.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |